NEBO-224

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNEBO-224
Drug Alias Namebone marrow stem cell therapy (Neuro Bioscience/RLI)NEBO-224
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Osteogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGibraltar
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRLI Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRLI LtdNeuro Bioscience
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A